Tempus AI Soars as Merck-Moderna Cancer Trial Validates Personalis Acquisition

기사 요약

Shares of Tempus AI are surging Wednesday morning as traders connected the dots between a landmark clinical trial win and Tempus’s recent multi-billion dollar acquisition deal.